1 / 16

CDRH Initiatives for aging in place

This workshop, presented by Mary Brady, Senior Policy Advisor at CDRH, FDA, covers final guidance for home use devices and mobile medical applications. Topics addressed include definitions, design considerations, risk management, user and environmental considerations, labeling, maintenance, and more. The session also discusses mobile medical apps regulation, intended use criteria, FDA oversight, and research recommendations for technology in healthcare. Attendees will gain insights into user training, emergency device handling, disposal, hygiene, and post-market considerations. Have any questions?

pearsonl
Download Presentation

CDRH Initiatives for aging in place

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CDRH Initiatives for aging in place NIH Aging in Place Workshop September 10-11, 2014 Presented by Mary Brady, MSN, RN Senior Policy Advisor Center for Devices and Radiological Health Food and Drug Administration

  2. I will address: Final Guidance for Home Use Devices Final Guidance for Mobile Medical Applications Research Recommendations to Further Policy

  3. Home use FINal guidance

  4. Home use final guidance • Provides definitions - Home Use device - User - Lay - Qualified health care professional - Professional health care facility

  5. Home use final guidance Leads to useful and usable labeling design user environment

  6. Design considerations Risk management Software Lock-out mechanisms Maintenance Calibration Mechanical Electrical issues (supply mains, power sources, permanently installed devices, outlets, adapters, outages, EMC, wireless, alarm systems)

  7. User considerations Physical - Size, mobility, dexterity, strength, stamina Sensory/perceptual - Vision, hearing, tactile Cognitive - Literacy, comprehension, learning Emotional - New diagnosis, treatment, device

  8. Environmental considerations Location Contaminants Water supply Temperature Dampness and humidity Atmospheric pressure changes Air flow Travel Fluid exposure Storage

  9. Other sections in the final guidance Human factors User training Labeling Handling the device in an emergency Disposal Hygienic maintenance Post market considerations

  10. Mobile medical applications final guidance

  11. Two categories of mobile applications Those that meet the definition of a medical device - pose a risk to the patient’s safety - referred to as “mobile medical apps” Those that do not meet the definition of a medical device - not regulated by FDA

  12. Mobile medical apps intended use To be used as an accessory to a regulated medical device To transform a mobile platform into a regulated medical device

  13. Criteria for fda to exercise regulatory oversight Connecting to a medical device to control the device Displaying, storing, analyzing, or transmitting patient-specific medical device data Transforming the mobile platform into a regulated medical device Providing patient-specific diagnosis or treatment recommendations.

  14. Criteria for fda to exercise enforcement discretion Providing supplemental clinical care Providing patients the tools to enable easy access, track and organize their health information Helping patients documentand communicate to providers potential medical conditions Performing calculations used in clinical practice Enabling individuals to interact with PHR or HER systems

  15. Research recommendations Readmission rates of people with technology Purchasing equipment after a period of reimbursement

  16. QUESTIONS???

More Related